Therapeutic agent for diabetic gangrene comprising factor XIII

Details Therapeutic agent for diabetic gangrene comprising factor XIII Therapeutic agent for diabetic gangrene comprising factor XIII

1991-02-15

1992-11-17

Schain, Howard E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

424 9461, 424 9463, 424 9464, 424 9465, 424 9466, 514 2, 514 8, 514 12, 530381, A61K 3516, A61K 3702, A61K 3748, A61K 3550

Patent

active

051643731

ABSTRACT:
An agent for the therapy of diabetic gangrene is described containing blood coagulation factor XIII as the active ingredient.

REFERENCES:
patent: 3904751 (1975-09-01), Zwisler et al.
patent: 3931399 (1976-01-01), Bohn et al.
patent: 4285933 (1981-08-01), Fukushima et al.
patent: 4297344 (1981-10-01), Schwinn et al.
patent: 4327086 (1982-04-01), Fukushima et al.
patent: 4597899 (1986-07-01), Falke
patent: 4909251 (1990-03-01), Seelich

Affiliated with

Also associated with

Rating

Therapeutic agent for diabetic gangrene comprising factor XIII does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic agent for diabetic gangrene comprising factor XIII, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent for diabetic gangrene comprising factor XIII will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1172128